این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Iranian Heart Journal، جلد ۴، شماره ۴، صفحات ۴۴-۴۸
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی PRESCRIBED DRUGS FOR SECONDARY PREVENTION IN POSTMYOCARDIAL INFARCTION PATIENTS IN SHIRAZ
چکیده انگلیسی مقاله Background- Coronary artery diseases are the leading cause of death in the ‎developing countries, including Iran. Continued advances in medical and surgical ‎techniques, combined with effective and focused programs in cardiac rehabilitation, ‎are critical to reduce the overall incidence of coronary artery diseases. Now it is ‎recommended that all survivors of acute myocardial infarction receive antiplatelet ‎drugs, beta-adrenergic blocking agents, ACE inhibitors and statins. However, studies ‎show that the ratio of prescribing these drugs is far lower than ideal. This study has ‎been designed to evaluate these ratios in Iran‏.‏‎‎ Methods- In a descriptive, cross-sectional retrograde study, the ratio of prescribing the ‎above-mentioned drugs in 912 randomly selected patients from Shiraz University ‎hospitals who met WHO criteria for myocardial infarction from March 2000 to March ‎‎2001 were studied. Trained medical students recorded demographical data, location of ‎infarction, risk factors and pharmacologic therapy at the time of the discharge of the ‎patients from the medical recording files in a standardized questionnaire‏.‏‎‎ Results- The mean age of the studied patients was 61±12 years. The most frequently ‎prescribed drugs were antiplatelet agents and the least frequent ones were statins. ‎There were statistically significant relationships between cigarette smoking and beta-‎adrenergic blocking agents administration, hyperlipidemia and statins administration ‎and hypertension and ACE inhibitors administration‏.‏‎‎ Conclusion- There is a need for improvement in secondary prevention in patients with ‎myocardial infarction at the time of hospital discharge, and risk factor evaluation and ‎suitable drug therapy is necessary for secondary prevention in Shiraz University ‎hospitals (Iranian Heart Journal 2003; 4 (4):44-48).‎
کلیدواژه‌های انگلیسی مقاله POST-MI N DRUGS N SECONDARY PREVENTION
نویسندگان مقاله M. J. Zibaeenezhad |
Cardiovascular Research Center, Nemazi Hospital, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

A. Mowla |


A. Zareefar |


M. A . Babaei |


نشانی اینترنتی http://journal.iha.org.ir/article_83645_9aa7b6979ab0baa91c693664dbb31407.pdf
فایل مقاله اشکال در دسترسی به فایل - ./files/site1/rds_journals/162/article-162-1424259.pdf
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات